Beyond BMI: Organ Size and Obesity-Driven Cancer Risk

New research indicates that the link between obesity and the risk of certain cancers is driven by an increase in the number of cells within organs, a biological process known as hyperplasia.

The findings, detailed in a multicomponent study by Pénisson S, et al. And published in Cancer Res. in 2026, suggest that hyperplasia contributes to the development of at least some solid tumors.

The Role of Cellular Burden

The study clarifies the mechanism of organ growth associated with weight gain. It found that hyperplasia, rather than hypertrophy—the increase in the size of existing cells—accounts for the majority of organ growth when a person gains weight.

This increase in the total number of cells creates a higher cellular burden within the organ. The presence of additional cells increases the likelihood of copying errors occurring during cell division.

These copying errors can lead to mutations, which in turn increase the potential for cancer development.

Limitations of BMI in Cancer Risk Assessment

Medical practitioners have traditionally relied on body mass index (BMI) to assess obesity-driven health risks. However, emerging evidence suggests that BMI alone may not be the most accurate predictor of cancer risk.

Cristian Tomasetti, Ph.D., has highlighted that significant variations in organ size exist among patients who share the same BMI.

Because cancer risk is tied to the number of cells and the resulting cumulative mutations within tissues, organ size may be a more precise indicator of risk than a general weight-to-height ratio.

Clinical Implications of Hyperplasia

The shift in focus from general obesity to organ-specific hyperplasia provides a more detailed understanding of why some individuals with obesity are more susceptible to certain cancers than others.

By identifying the increase in cell count as a primary driver of malignancy, the research moves the conversation beyond simple weight metrics toward a more nuanced understanding of cellular burden.

This perspective emphasizes that the biological impact of weight gain varies between individuals, as the degree of organ hyperplasia can differ even when BMI remains constant.